NCT05402527

Brief Summary

Nowadays, many persons who exercise consume dietary supplements. Previous scientific studies have found that protein supplementation increases muscle mass when combined with an exercise program. In addition, vitamin D probably improves performance and muscle function. Likewise, ω3 fatty acids, apart from improving cardiovascular function, may also increase protein synthesis and performance. Thus, the aim of this study is to investigate the efficacy of a novel aquaculture-based sport supplement of proteins, ω3 fatty acids and vitamin D on physical performance, body composition, and the biochemical profile of persons following high-intensity functional training (HIFT). The efficacy of the experimental supplement (E) will be compared with whey protein (W) and maltodextrin (a carbohydrate) as placebo (P). Thirty healthy trained individuals (15 male and 15 female), aged 18-35, will take E, W, and P during three 6-week periods of HIFT (a different supplement each period) with three workouts a week and a washout (no supplement) period of 2 weeks between supplementation periods. E is a combination of powder, containing protein and vitamin D, and capsules containing ω3 fatty acids. When on E, participants will receive 0.6 g protein/kg body weight, 20 μg vitamin D, and 1.8 g ω3 fatty acids daily. When on W, they will receive 0.6 g protein/kg body weight and, when on P, they will receive 0.6 g maltodextrin/kg body weight daily. The order of E, W, and P will be random and counterbalanced. Throughout the study, participants will be on isoenergetic nutritional plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day. Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition prior to the first supplementation period, between periods, and after the third period. Also, blood amino acids, fatty acid acids, vitamin D, hematology, biochemistry, and hormones will be measured. To avoid bias, assessors will not know which supplement each participant is taking during each period. The main hypotheses of the study are: 1) Consumption of E will increase lean body mass compared to W and P; 2) consumption of E will improve muscle strength, muscle endurance, and aerobic capacity compared to W and P; and 3) consumption of E will result in a better blood amino acid, fatty acid, and vitamin D profile.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 2, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

1.4 years

First QC Date

April 22, 2022

Last Update Submit

October 3, 2023

Conditions

Outcome Measures

Primary Outcomes (12)

  • Plasma amino acid profile pre-supplementation

    Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.

    Within 2 days before the beginning of supplementation.

  • Plasma amino acid profile post-supplementation

    Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.

    Within 2 days after the end of supplementation.

  • Whole-blood fatty acid profile pre-supplementation

    Whole-blood fatty acid profile (that is, the concentration of each individual fatty acid) will be determined by gas chromatography.

    Within 2 days before the beginning of supplementation.

  • Whole-blood fatty acid profile post-supplementation

    Whole-blood fatty acid profile (that is, the concentration of each individual fatty acid) will be determined by gas chromatography.

    Within 2 days after the end of supplementation.

  • Maximal dynamic strength of shoulder muscles pre-supplementation

    Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.

    Within 2 weeks before the beginning of supplementation.

  • Maximal dynamic strength of shoulder muscles post-supplementation

    Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.

    Within 2 weeks after the end of supplementation.

  • Force-velocity relationship of knee flexors and extensors pre-supplementation

    Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.

    Within 2 weeks before the beginning of supplementation.

  • Force-velocity relationship of knee flexors and extensors post-supplementation

    Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.

    Within 2 weeks after the end of supplementation.

  • Aerobic fitness pre-supplementation

    Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.

    Within 2 weeks before the beginning of supplementation.

  • Aerobic fitness post-supplementation

    Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.

    Within 2 weeks after the end of supplementation.

  • Lean and fat mass pre-supplementation

    Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.

    Within 2 weeks before the beginning of supplementation.

  • Lean and fat mass post-supplementation

    Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.

    Within 2 weeks after the end of supplementation.

Secondary Outcomes (16)

  • Plasma vitamin D concentration pre-supplementation

    Within 2 days before the beginning of supplementation.

  • Plasma vitamin D concentration post-supplementation

    Within 2 days after the end of supplementation.

  • Muscle endurance pre-supplementation

    Within 2 weeks before the beginning of supplementation.

  • Muscle endurance post-supplementation

    Within 2 weeks after the end of supplementation.

  • Force-velocity relationship of shoulder muscles pre-supplementation

    Within 2 weeks before the beginning of supplementation.

  • +11 more secondary outcomes

Study Arms (6)

Fish nutrients - Whey protein - Maltodextrin

OTHER

Participants will receive fish nutrients, whey protein, and maltodextrin in this order.

Dietary Supplement: Fish nutrientsDietary Supplement: Whey proteinDietary Supplement: Maltodextrin

Fish nutrients - Maltodextrin - Whey protein

OTHER

Participants will receive fish nutrients, maltodextrin, and whey protein in this order.

Dietary Supplement: Fish nutrientsDietary Supplement: Whey proteinDietary Supplement: Maltodextrin

Whey protein - Fish nutrients - Maltodextrin

OTHER

Participants will receive whey protein, fish nutrients, and maltodextrin in this order.

Dietary Supplement: Fish nutrientsDietary Supplement: Whey proteinDietary Supplement: Maltodextrin

Whey protein - Maltodextrin - Fish nutrients

OTHER

Participants will receive whey protein, maltodextrin, and fish nutrients in this order.

Dietary Supplement: Fish nutrientsDietary Supplement: Whey proteinDietary Supplement: Maltodextrin

Maltodextrin - Fish nutrients - Whey protein

OTHER

Participants will receive maltodextrin, fish nutrients, and whey protein in this order.

Dietary Supplement: Fish nutrientsDietary Supplement: Whey proteinDietary Supplement: Maltodextrin

Maltodextrin - Whey protein - Fish nutrients

OTHER

Participants will receive maltodextrin, whey protein, and fish nutrients in this order.

Dietary Supplement: Fish nutrientsDietary Supplement: Whey proteinDietary Supplement: Maltodextrin

Interventions

Fish nutrientsDIETARY_SUPPLEMENT

Intake of fish protein, omega-3 fatty acids, and vitamin D

Fish nutrients - Maltodextrin - Whey proteinFish nutrients - Whey protein - MaltodextrinMaltodextrin - Fish nutrients - Whey proteinMaltodextrin - Whey protein - Fish nutrientsWhey protein - Fish nutrients - MaltodextrinWhey protein - Maltodextrin - Fish nutrients
Whey proteinDIETARY_SUPPLEMENT

Intake of whey protein

Fish nutrients - Maltodextrin - Whey proteinFish nutrients - Whey protein - MaltodextrinMaltodextrin - Fish nutrients - Whey proteinMaltodextrin - Whey protein - Fish nutrientsWhey protein - Fish nutrients - MaltodextrinWhey protein - Maltodextrin - Fish nutrients
MaltodextrinDIETARY_SUPPLEMENT

Intake of maltodextrin

Fish nutrients - Maltodextrin - Whey proteinFish nutrients - Whey protein - MaltodextrinMaltodextrin - Fish nutrients - Whey proteinMaltodextrin - Whey protein - Fish nutrientsWhey protein - Fish nutrients - MaltodextrinWhey protein - Maltodextrin - Fish nutrients

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Regular training (mixed endurance and resistance training 3-6 times a week, 50 min each session, for the past 4-6 months) as assessed by gym records or questionnaires.
  • Clearance from a pathologist or cardiologist to perform maximal exercise.
  • Mixed isoenergetic diet for the past 4-6 months.

You may not qualify if:

  • Smoking (even one cigarette or nicotine-containing device over the past 6 months).
  • Any injuries to the musculoskeletal system that could interfere with the execution of training.
  • Chronic disease.
  • Fish or oyster allergy.
  • Milk allergy.
  • Pregnancy, lactation or planning a pregnancy within the duration of the study.
  • Regular use of prescription medicine or supplements that might affect muscle function or recovery over the past month.
  • Intermittent or religious fasting.
  • Any vegetarian, ketogenic and protein diet.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laboratory of Evaluation of Human Biological Performance

Thessaloniki, 57001, Greece

Location

MeSH Terms

Interventions

Whey Proteinsmaltodextrin

Intervention Hierarchy (Ancestors)

Milk ProteinsAnimal Proteins, DietaryDietary ProteinsProteinsAmino Acids, Peptides, and ProteinsWheyMilkDairy ProductsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants are instructed not to disclose the supplement they are taking to their trainers, investigators, or outcome assessors.
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2022

First Posted

June 2, 2022

Study Start

November 8, 2021

Primary Completion

March 31, 2023

Study Completion

September 30, 2023

Last Updated

October 5, 2023

Record last verified: 2023-10

Locations